CONCORDBIO
Concord Biotech Limited
Pharmaceuticals · ₹13,651 Cr market cap
An R&D-driven biopharma company engaged in manufacturing fermentation-based active pharmaceutical ingredients for immunosuppressants and oncology applications. Established in 1984, the company specializes in complex fermentation technology and serves domestic and international pharmaceutical markets with differentiated API solutions. Its focus on bioprocess innovation and vertical integration in fermentation-based manufacturing distinguishes it within the competitive global pharmaceutical ingredients landscape.
3
Tracked investors holding
0
Tracked moves
₹1,305
Share price
Top investors holding Concord Biotech Limited
1.91%
1.52%
Track smart money in Concord Biotech Limited
Get alerted when a top investor buys or sells.
Get started